Times of Israel: Oral insulin, by Israeli mom-son team, starts final trials to become world’s 1st

“This has the potential to improve lives of hundreds of millions of diabetics worldwide,” Oramed CEO Nadav Kidron told The Times of Israel. “And by improving treatment it can reduce complications and, in turn, reduce the cost of treating diabetics.”

Read more here.  

You may also be interested

Join our mailing list

Skip to content